Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Carcinoma, Epidermoid

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Carcinoma, Epidermoid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Endo-Sakamoto, Y; Fukumoto, C; Kasamatsu, A; Ogawara, K; Shida-Sakazume, T; Shiiba, M; Shimada, K; Tanzawa, H; Unozawa, M; Uzawa, K; Yokoe, H1
Beaugie, C; Byrne, SN; Halliday, GM; Leighton, S; O'Sullivan, C1
Berman, B; Cockerell, CJ1
Rhee, SG; Shukla, SD; Thurston, AW1
Chen, LL; Kreutzer, DL; Mann, EA; Spiro, JD1
Chow, KC; Wang, LS; Wu, YC1

Other Studies

6 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Carcinoma, Epidermoid

ArticleYear
Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
    PloS one, 2015, Volume: 10, Issue:3

    Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Mouth; Mouth Neoplasms; Neoplasm Invasiveness; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; RNA, Messenger; Tumor Cells, Cultured; Up-Regulation

2015
The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation.
    The American journal of pathology, 2011, Volume: 179, Issue:1

    Topics: Adult; Animals; Blotting, Western; Carcinoma, Squamous Cell; Female; Fibroblasts; Fluorescent Antibody Technique; Humans; Inflammation; Interleukin-33; Interleukins; Keratinocytes; Mast Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neutrophils; Platelet Activating Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin; Skin Neoplasms; Ultraviolet Rays

2011
Pathobiology of actinic keratosis: ultraviolet-dependent keratinocyte proliferation.
    Journal of the American Academy of Dermatology, 2013, Volume: 68, Issue:1 Suppl 1

    Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Proliferation; Cell Transformation, Neoplastic; DNA; fas Receptor; Humans; Immune Tolerance; Inflammation; Keratinocytes; Keratosis, Actinic; Platelet Activating Factor; Signal Transduction; Skin; Skin Neoplasms; Sunlight; T-Lymphocytes, Regulatory; Tumor Suppressor Protein p53; Ultraviolet Rays; Urocanic Acid

2013
Role of guanine nucleotide-binding protein and tyrosine kinase in platelet-activating factor activation of phospholipase C in A431 cells: proposal for dual mechanisms.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:2

    Topics: Carcinoma, Squamous Cell; Enzyme Activation; Epidermal Growth Factor; GTP Phosphohydrolases; GTP-Binding Proteins; Humans; Phosphorylation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein-Tyrosine Kinases; Proto-Oncogene Proteins pp60(c-src); Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tumor Cells, Cultured; Type C Phospholipases

1993
Phospholipid metabolite expression by head and neck squamous cell carcinoma.
    Archives of otolaryngology--head & neck surgery, 1994, Volume: 120, Issue:7

    Topics: Aged; Analysis of Variance; Animals; Carcinoma, Squamous Cell; Dinoprostone; Epidermal Growth Factor; Evaluation Studies as Topic; Fibroblasts; Head and Neck Neoplasms; Humans; Immune Tolerance; Interleukin-1; Leukotriene B4; Lipopolysaccharides; Middle Aged; Neoplasm Staging; Phenotype; Platelet Activating Factor; Radioimmunoassay; Regression Analysis; Tumor Cells, Cultured

1994
Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells.
    Scandinavian journal of gastroenterology, 2002, Volume: 37, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Butyrates; Carcinoma, Squamous Cell; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Esophageal Neoplasms; Female; Humans; Immunohistochemistry; Interleukin-6; Isoenzymes; Male; Membrane Proteins; Middle Aged; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandin-Endoperoxide Synthases; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

2002